SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-06-003585
Filing Date
2006-03-16
Accepted
2006-03-16 16:51:23
Documents
14
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2167642z10-k.htm 10-K 946098
2 EXHIBIT 10.9 a2167642zex-10_9.htm EX-10.9 26546
3 EXHIBIT 10.11 a2167642zex-10_11.htm EX-10.11 227264
4 EXHIBIT 10.35 a2167642zex-10_35.htm EX-10.35 20740
5 EXHIBIT 10.36 a2167642zex-10_36.htm EX-10.36 18245
6 EXHIBIT 10.37 a2167642zex-10_37.htm EX-10.37 7663
7 EXHIBIT 10.38 a2167642zex-10_38.htm EX-10.38 2761
8 EXHIBIT 10.40 a2167642zex-10_40.htm EX-10.40 1817
9 EXHIBIT 21 a2167642zex-21.htm EX-21 2975
10 EXHIBIT 23.1 a2167642zex-23_1.htm EX-23.1 2536
11 EXHIBIT 23.2 a2167642zex-23_2.htm EX-23.2 1946
12 EXHIBIT 31.1 a2167642zex-31_1.htm EX-31.1 6164
13 EXHIBIT 31.2 a2167642zex-31_2.htm EX-31.2 5931
14 EXHIBIT 32.1 a2167642zex-32_1.htm EX-32.1 3858
  Complete submission text file 0001047469-06-003585.txt   1275842
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 06692610
SIC: 2834 Pharmaceutical Preparations